We are live on ! Find out more
PMC

PharMerica Corporation
PMC

Delisted

PMC was delisted on the 7th of December, 2017.

161 hedge funds and large institutions have $825M invested in PharMerica Corporation in 2014 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 69 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more capital invested

Capital invested by funds: $627M → $825M (+$198M)

20% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 20

2% more funds holding

Funds holding: 158161 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

26% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 69

55% less call options, than puts

Call options by funds: $786K | Put options by funds: $1.74M

Holders
161
Holders Change
+3
Holders Change %
+1.9%
% of All Funds
4.65%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
24
Increased
51
Reduced
69
Closed
20
Calls
$786K
Puts
$1.74M
Net Calls
-$954K
Net Calls Change
-$801K
Name Holding Trade Value Shares
Change
Change in
Stake
PIA
151
Piedmont Investment Advisors
North Carolina
$2.8K -$368 -15 -13%
GAM
152
Gemmer Asset Management
California
$2K +$2.06K +84 New
Envestnet Asset Management
153
Envestnet Asset Management
Illinois
$1K -$15K -609 -93%
Creative Planning
154
Creative Planning
Kansas
$1K
Fifth Third Bancorp
155
Fifth Third Bancorp
Ohio
$1K
First Manhattan
156
First Manhattan
New York
$1K
CFA
157
Carroll Financial Associates
North Carolina
$1K +$344 +14 +108%
MFS
158
MSI Financial Services
Massachusetts
$1K +$589 +24 New
Manulife (Manufacturers Life Insurance)
159
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$631 -$12.8K -521 -2%
QBFM
160
QS Batterymarch Financial Management
New York
-$5.67M -263,680 Closed
Boston Partners
161
Boston Partners
Massachusetts
-$5.13M -238,661 Closed
OAM
162
Oxford Asset Management
United Kingdom
-$4.26M -198,168 Closed
TBAM
163
True Bearing Asset Management
California
-$1.19M -55,314 Closed
HHC
164
Hutchin Hill Capital
New York
-$1.14M -52,800 Closed
Citadel Advisors
165
Citadel Advisors
Florida
-$860K -39,990 Closed
ARTA
166
A.R.T. Advisors
New York
-$673K -31,312 Closed
SI
167
Stephens Inc
Arkansas
-$530K -24,645 Closed
DIA
168
Denver Investment Advisors
Colorado
-$525 -24,405 Closed
PA
169
Profund Advisors
Maryland
-$367K -17,063 Closed
Nomura Holdings
170
Nomura Holdings
Japan
-$296K -13,768 Closed
HCM
171
Highbridge Capital Management
New York
-$245K -11,393 Closed
Verition Fund Management
172
Verition Fund Management
Connecticut
-$213K -9,911 Closed
ICM
173
ICC Capital Management
Florida
-$71K -3,291 Closed
BNP Paribas Financial Markets
174
BNP Paribas Financial Markets
France
-$8.28K -385 Closed
NSEDCP
175
NJ State Employees Deferred Compensation Plan
New Jersey
-$8K -385 Closed

PMC Hedge Fund Activity: Q1 2014 in Review

161 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in PharMerica Corporation (PMC) for Q1 2014, worth a combined $825M — up 32% from $627M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PMC positions and 20 closed out — a net gain of 4 holders — while 51 added to existing stakes and 69 trimmed.

The largest buyer was Ameriprise, adding an estimated $12M. The largest seller was Heartland Advisors, cutting an estimated $18M.

  • 161 institutional investors held PharMerica Corporation (PMC) as of Q1 2014, up from 158 in Q4 2013.
  • Funds reported $825M of PharMerica Corporation stock for Q1 2014, up 32% quarter-over-quarter.
  • 24 funds opened new PharMerica Corporation positions in Q1 2014 and 20 closed out, a net change of +4 holders.
  • The largest PharMerica Corporation buyer in Q1 2014 was Ameriprise, an estimated $12M added.
  • The largest PharMerica Corporation seller in Q1 2014 was Heartland Advisors, an estimated $18M sold.

Based on aggregated 13F filings for Q1 2014.